DiviDrip · TCRX

TCRX — TScan Therapeutics, Inc.

TCRX is TScan Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.38. Market cap: $25M. Capital Quality Rank: 32/100 — Stagnant mediocrity.

Stock snapshot

Price$0.38
Market cap$25M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)32 / 100 · Stagnant mediocrity
ROIC (TTM)-3300.3%
Revenue CAGR (3y)-8.6%
Shareholder buyback yield-13.71%
Altman Z-score zoneDistress

About TCRX

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

Listed2021Employees142HQWaltham, MASectorHealthcareWebsitetscan.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TCRX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TCRX's current stock price?

TCRX (TScan Therapeutics, Inc.) is currently trading at $0.38.

Does TCRX pay a dividend?

TCRX (TScan Therapeutics, Inc.) does not currently pay a regular dividend.

What is TCRX's Capital Quality Rank?

TCRX has a Capital Quality Rank of 32/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TCRX in DiviDrip

Add TCRX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow